A Collaboration with the University of Pittsburgh

Chief Justice refuses to stay drug patent ruling

[JURIST] US Supreme Court [official website] Chief Justice John Roberts denied [text, PDF] the request of Teva Pharmaceuticals USA [corporate website] for a stay on the lower court ruling. The appeals court's ruling made Teva's Copaxone drug available to be produced in a generic form [opinion]. Teva sought to have this delayed until the Supreme Court is able to hear the dispute after the court granted certiorari [order list, PDF] last month. Roberts reasoned that the likelihood that Teva would suffer irreparable harm was too remote to justify the stay. The generic rivals of Teva argued that a stay would delay their entry into the market, which could be as early as late May. There is the possibility that Teva could seek a stay from a different justice, but such relief is rarely granted.

The Supreme Court also denied review [JURIST report] of Roman Catholic Archbishop v. Sebelius and Priests for Life v. Health and Human Services Department [dockets] on Monday. These petitions sought the court's review of the validity of government rules to exempt religious employers from having to follow the birth-control mandate in the Patient Protection and Affordable Care Act [text]. These cases are already scheduled to be heard by the US Court of Appeals for the District of Columbia [official website] on May 8.

About Paper Chase

Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible format.

© Copyright JURIST Legal News and Research Services, Inc., 2013.